The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shakaryan A.K.

Chumakov Federal Research Center for Research and Development of Immunobiological Drugs;
Pirogov Russian National Research Medical University

Pylaeva S.K.

Pirogov Russian National Research Medical University

Perekopskaya N.E.

Municipal Infectious Diseases Hospital No.1

Sayfullin R.F.

Pirogov Russian National Research Medical University

Belyakova A.V.

Chumakov Federal Research Center for Research and Development of Immunobiological Drugs

Guillain—Barre syndrome with cranial nerve damage as complication of COVID-19

Authors:

Shakaryan A.K., Pylaeva S.K., Perekopskaya N.E., Sayfullin R.F., Belyakova A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9): 100‑103

DOI: 10.17116/jnevro2021121091100

Read: 2595 times

Download PDF (RU)
Contact the author
Table of contents

GUILLAIN—BARRE SYNDROME WITH CRANIAL NERVE DAMAGE AS COMPLICATION OF COVID-19
GUILLAIN—BARRE SYNDROME WITH CRANIAL NERVE DAMAGE AS COMPLICATION OF COVID-19

To cite this article:

Shakaryan AK, Pylaeva SK, Perekopskaya NE, Sayfullin RF, Belyakova AV. Guillain—Barre syndrome with cranial nerve damage as complication of COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9):100‑103. (In Russ.)
https://doi.org/10.17116/jnevro2021121091100

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Coro­navirus infe­ction as a risk factor in occlusive-stenotic lesions of the brachiocephalic arte­ries. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):44-52
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
A clinical case of the aortic rupture after SARS-CoV-2 in the patient with Stickler syndrom. Russian Journal of Preventive Medi­cine. 2025;(3):103-106
Post-COVID syndrome: orga­nizing COVID-19-associated pneumonia. Clinical case. Journal of Respiratory Medi­cine. 2025;(1):65-72
mRNA cancer vaccines: features of problems and collisions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):3-16
SpO2/RR index in choosing the method for correction of acute respiratory failure in COVID-19 patients. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):50-58
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
Impact of the COVID-19 epidemic on students’ health. Part II. Features of hemo­dynamics, vege­tative regu­lation, resu­lts of psychological and stress resi­stance testing among students depe­nding on the COVID-19 presence in their medi­cal history. Russian Journal of Preventive Medi­cine. 2025;(4):94-101
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
Abstract:

The article presents a clinical example of Guillain—Barre syndrome with a predominant involvement of cranial nerves, which developed after COVID-19. Comprehensive clinical and laboratory diagnostics, including examination of cerebrospinal fluid, electromyography, examination for possible etiological infectious agents, was carried out. A course of pathogenetic therapy was used in the form of plasmapheresis sessions, supportive therapy. A good clinical effect was obtained. To this moment, only a few cases of the development of Guillain-Barré syndrome after a new coronavirus infection have been described. The peculiarity of our case is the development of a clinical picture of insufficiency of predominantly cranial nerves with subclinical involvement of the nerves of the extremities.

Keywords:

Guillain—Barre syndrome
COVID-19
complication
cranial form

Authors:

Shakaryan A.K.

Chumakov Federal Research Center for Research and Development of Immunobiological Drugs;
Pirogov Russian National Research Medical University

Pylaeva S.K.

Pirogov Russian National Research Medical University

Perekopskaya N.E.

Municipal Infectious Diseases Hospital No.1

Sayfullin R.F.

Pirogov Russian National Research Medical University

Belyakova A.V.

Chumakov Federal Research Center for Research and Development of Immunobiological Drugs

Received:

02.04.2021

Accepted:

14.05.2021

Close metadata

References:

  1. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22.  https://doi.org/10.1016/j.bbi.2020.03.031
  2. Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699-702.  https://doi.org/10.1002/jmv.25915
  3. Wang L, Shen Y, Li M, et al. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. 2020;267(10):2777-2789. https://doi.org/10.1007/s00415-020-09974-2
  4. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-727.  https://doi.org/10.1016/S0140-6736(16)00339-1
  5. Yang YR, Liu SL, Qin ZY, et al. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell Mol Neurobiol. 2008;28(5):737-744.  https://doi.org/10.1007/s10571-007-9257-7
  6. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-133.  https://doi.org/10.1159/000324710
  7. Suponeva NA, Shakaryan AK, Rakhteenko AV, Piradov MA, Mitrofanova IV, Prytkova MI, Leont’ieva IY, Shakhgildyan SV, Morozova NS. Clinical and Laboratory Features, Treatment and Prognosis in Children with Guillian—Barre Syndrome. Children infections. 2015;14(3):17-26. (In Russ.). https://doi.org/10.22627/2072-8107-2015-14-3-17-26
  8. Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110-1115. https://doi.org/10.1212/WNL.51.4.1110
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.